Singapore markets closed
Straits Times Index
3,280.10 -7.65 (-0.23%) Nikkei
37,934.76 +306.28 (+0.81%) Hang Seng
17,651.15 +366.61 (+2.12%) FTSE 100
8,139.83 +60.97 (+0.75%) Bitcoin USD
63,777.78 -742.41 (-1.15%) CMC Crypto 200
1,327.88 -68.66 (-4.92%)
Open Orphan PLC (CRO.MU)
Munich - Munich Delayed price. Currency in EUR
Add to watchlist
At close: 09:09AM CEST
| Previous close | 0.2080 |
| Open | 0.2080 |
| Bid | 0.0000 x N/A |
| Ask | 0.0000 x N/A |
| Day's range | 0.2080 - 0.2080 |
| 52-week range | 0.1740 - 0.2300 |
| Volume | |
| Avg. volume | 0 |
| Market cap | N/A |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
Simply Wall St.Is hVIVO plc's (LON:HVO) Recent Stock Performance Tethered To Its Strong Fundamentals?
hVIVO's (LON:HVO) stock is up by a considerable 5.7% over the past month. Given that the market rewards strong...
- Reuters
hVIVO raises 2023 revenue view on demand for respiratory therapy testings
Drugmakers are in a race to develop vaccines and drugs to treat respiratory diseases caused by respiratory syncytial virus and COVID-19, resulting in increased demand for clinical testing of the products. The contract research organisation now expects its annual revenue to be 55 million pounds ($68.8 million), compared with 53 million pounds it previously expected.
© 2024 Yahoo. All rights reserved.